Adjusted EBITDA Improvement
Adjusted EBITDA from continuing operations improved from a loss of $2.7 million in Q1 2024 to a positive $843,000 in Q1 2025, marking a $3.5 million turnaround.
Gross Margin Expansion in Tubular Segment
Gross margin in the Tubular segment increased from 12.3% to 24.8%, with adjusted EBITDA rising nearly 5 times to $1.3 million.
Specialty Chemicals Segment Performance
Gross profit in Specialty Chemicals increased by 131%, from $1.6 million in Q1 2024 to $3.7 million in Q1 2025, with gross margin expanding from 7.6% to 21%.
Successful Strategic Repositioning
Company strategically exited low-margin, low-value volume streams, resulting in a 22.8% reduction in pounds shipped but a 13.5% increase in average selling prices.
Increased Market Engagement
Average daily trading volume increased to roughly 63,000 shares in Q1 2025, a 160% lift versus Q1 2024.
Strong Balance Sheet
Ended the quarter with $14.3 million in cash and no debt before the divestiture of Bristol assets for $45 million.